Conditions: Actinic Keratosis
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 189
Healthy volunteers: no

Brief summary:
The objective of the trial is to investigate the Safety of LEO 43204 0.018%, 0.037% and 0.1% for actinic keratosis applied once daily for three consecutive days on face/chest, scalp and trunk/extremities, respectively.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: LEO 43204
Intervention descriptions: intervention 1: Treatment of actinic keratosis

Protocol document: